GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Simcere Pharmaceutical Group Ltd (STU:S2P) » Definitions » Land And Improvements

Simcere Pharmaceutical Group (STU:S2P) Land And Improvements : €60.2 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Simcere Pharmaceutical Group Land And Improvements?

Simcere Pharmaceutical Group's land and improvements for the quarter that ended in Dec. 2024 was €60.2 Mil.

Simcere Pharmaceutical Group's quarterly land and improvements declined from Dec. 2023 (€54.4 Mil) to Jun. 2024 (€0.0 Mil) but then increased from Jun. 2024 (€0.0 Mil) to Dec. 2024 (€60.2 Mil).

Simcere Pharmaceutical Group's annual land and improvements increased from Dec. 2022 (€41.4 Mil) to Dec. 2023 (€54.4 Mil) and increased from Dec. 2023 (€54.4 Mil) to Dec. 2024 (€60.2 Mil).


Simcere Pharmaceutical Group Land And Improvements Historical Data

The historical data trend for Simcere Pharmaceutical Group's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Simcere Pharmaceutical Group Land And Improvements Chart

Simcere Pharmaceutical Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Land And Improvements
Get a 7-Day Free Trial 28.08 31.04 41.36 54.43 60.19

Simcere Pharmaceutical Group Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.36 - 54.43 - 60.19

Simcere Pharmaceutical Group Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


Simcere Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
No. 699-18, Xuanwu Road, Xuanwu District, Jiangsu Province, Nanjing, CHN, 210042
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production, and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases, and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.

Simcere Pharmaceutical Group Headlines

No Headlines